K. Maas

Surgery as part of combined modality treatment in stage IIIB non-small cell lung cancer.

F. Schramel, C. Pitz, P. Hofman, 2002, The Annals of thoracic surgery.

Weekly chemoradiation (docetaxel/cisplatin) followed by surgery in stage III NSCLC; a multicentre phase II study.

H. Groen, E. Smit, F. Schramel, 2010, Anticancer research.

Excessive esophageal toxicity in patients with locally advanced non-small cell lung cancer treated with concurrent hypofractionated chemoradiotherapy and 3-weekly platinum doublet chemotherapy

E. Kouwenhoven, N. C. van der Voort van Zyp, C. G. Gadellaa-van Hooijdonk, 2022, Clinical and translational radiation oncology.

The influence of gemcitabine on the CD4/CD8 ratio in patients with solid tumours.

C. Bokemeyer, L. Kanz, M. Arning, 1997, Oncology reports.

Lung function changes and pulmonary complications in patients with stage III non-small cell lung cancer treated with gemcitabine/cisplatin as part of combined modality treatment.

J. Lammers, F. Schramel, P. Zanen, 2003, Lung cancer.

Repeat mediastinoscopy after neoadjuvant therapy for non-small cell lung cancer.

F. Schramel, K. Maas, 2003, Lung cancer.

Optimizing mutation and fusion detection in Non-Small Cell Lung Cancer by sequential DNA and RNA sequencing.

F. Smedts, A. Cleton-Jansen, T. van Wezel, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Sequencing chemotherapy, radiotherapy and surgery in combined modality treatment of stage III nonsmall cell lung cancer

E. Smit, F. Schramel, S. E. El Sharouni, 2007, Current opinion in pulmonary medicine.

Weekly short infusions of gemcitabine are not associated with suppression of lymphatic activity in patients with solid tumors.

C. Bokemeyer, L. Kanz, T. Daikeler, 1997, Anti-Cancer Drugs.

Activity of gemcitabine in platinum-resistant ovarian germ cell cancer.

C. Bokemeyer, L. Kanz, T. Daikeler, 1996, European journal of cancer.